News

Highlights from the phase III EPOCH trial

The EPOCH trial is the first phase III international study evaluating the use of Yttrium 90 radioembolization and chemotherapy for...

Immunotherapy has revolutionized the way cancer is treated by boosting the body’s natural immunological defenses to destroy tumour cells. While...

Colorectal (CRC) cancer screening and diagnosis during the COVID-19 pandemic in Quebec, Canada CRC is the third most common cancer...

A Swedish population study published this month in the Journal of the National Cancer Institute adds to the body of...

Adjuvant (post-surgical) chemotherapy is useful in reducing the risk of disease recurrence and improving survival in patients who have undergone...

The fecal immunochemical test (FIT) is a widely used colorectal cancer (CRC) screening test that uses a specific antibody to...

The EPOCH trial is the first phase III international study evaluating the use of Yttrium 90 radioembolization and chemotherapy for...

Immunotherapy has revolutionized the way cancer is treated by boosting the body’s natural immunological defenses to destroy tumour cells. While...

Colorectal (CRC) cancer screening and diagnosis during the COVID-19 pandemic in Quebec, Canada CRC is the third most common cancer...

A Swedish population study published this month in the Journal of the National Cancer Institute adds to the body of...

Adjuvant (post-surgical) chemotherapy is useful in reducing the risk of disease recurrence and improving survival in patients who have undergone...

The fecal immunochemical test (FIT) is a widely used colorectal cancer (CRC) screening test that uses a specific antibody to...